PennyStocks101 Reports 3 TOP Stocks to Watch Closely: Protalix Biotherapeutics, Opexa Therapeutics, and China Digital Tv Holding Co.

Beverly Hills, CA -- (SBWIRE) -- 02/05/2013 -- http://www.PennyStocks101.com - The US leader in microcap breakouts, offers a high quality stocks alert newsletter to investors looking for the best breakout stocks around. PennyStocks101 reports 3 penny stocks to keep an eye on for a possible bounce or more gains: PLX, OPXA, and STV

The market saw a bounce on Tuesday after U.S. home prices rose and strong earning reports came in. The Dow Jones industrial average gained 123 points as of 2:13 p.m. EST. The Standard & Poor's 500 gained 17 points to 1,513. The Nasdaq composite was up 41 points to 3,171.

1. Protalix Biotherapeutics (NYSE:PLX) - ORTHODONTIX INC. is engaged in the provision of practice management services to the Affiliated Practices pursuant to long-term Administrative Services Agreements with separately organized affiliated professional associations.

2. Opexa Therapeutics (NASDAQ:OPXA) - Opexa Therapeutics, Inc. develops and commercializes cell therapies to treat autoimmune diseases such as MS, rheumatoid arthritis, and diabetes.

3. China Digital Tv Holding Co. (NYSE:STV) - CHINA DIGITAL TV is the leading provider of conditional access systems to Chinas rapidly growing digital television market.

Pennystocks101.com educates and shows investors the inner workings of the volatile world of penny stocks by scouring the markets for the hottest penny stocks that look poised to break out. Discover the next hidden company to profit. Sign up for the free newsletter to receive the next big report soon. Join at: http://www.PennyStocks101.com

Sign Up at - http://www.PennyStocks101.com for more ideas to put on your radar.

Disclosure
Pennystocks101.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. This press release may contain several forward looking statements. Please read our report and visit our website for complete risks and disclosures.